NASDAQ : PRE
Prenetics Global Limited — Key statistics
Healthcare · Diagnostics & Research · Hong Kong
Last price 18.98 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 321.48M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 300.81M |
| Enterprise Value | 172.94M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 15.36M |
| Shares Outstanding | 16.94M |
| Shares Change (YoY) | +23.97% |
| Shares Change (QoQ) | +1.67% |
| Owned by Insiders (%) | 25.96% |
| Owned by Institutions (%) | 7.30% |
| Float | 12.54M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.95 |
| Forward PS | 0.93 |
| PB Ratio | 3.30 |
| P/TBV Ratio | 3.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.04 |
| Quick Ratio | 3.66 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -234.54 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -47.01% |
| Return on Assets (ROA) | -18.95% |
| Return on Invested Capital (ROIC) | -27.05% |
| Return on Capital Employed (ROCE) | -45.67% |
| Weighted Average Cost of Capital (WACC) | 6.21% |
| Revenue Per Employee | $1.58M |
| Profits Per Employee | -$479,551 |
| Employee Count | 98 |
| Asset Turnover | 0.88 |
| Inventory Turnover | 7.14 |
Taxes
| Measure | Value |
|---|
| Income Tax | 80,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.35 |
| 52-Week Price Change | +28.51% |
| 50-Day Moving Average | 22.07 |
| 200-Day Moving Average | 19.59 |
| Relative Strength Index (RSI) | 38.49 |
| Average Volume (20 Days) | 196,271 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 514,989 |
| Short Previous Month | 442,015 |
| Short % of Shares Out | 3.04% |
| Short % of Float | 4.11% |
| Short Ratio (days to cover) | 2.74 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 154.59M |
| Gross Profit | 89.30M |
| Operating Income | -53.48M |
| Pretax Income | -57.22M |
| Net Income | -47.00M |
| EBITDA | -53.97M |
| EBIT | -53.48M |
| Loss Per Share | -$2.93 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 128.56M |
| Total Debt | 682,000 |
| Net Cash | 127.88M |
| Net Cash Per Share | $7.55 |
| Equity (Book Value) | 92.92M |
| Book Value Per Share | 5.39 |
| Working Capital | 111.12M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -40.49M |
| Capital Expenditures | -208,000 |
| Depreciation & Amortization | -497,000 |
| Net Borrowing | -1.48M |
| Free Cash Flow | -40.70M |
| FCF Per Share | -$2.40 |
Margins
| Measure | Value |
|---|
| Gross Margin | 57.77% |
| Operating Margin | -34.59% |
| Pretax Margin | -37.02% |
| Profit Margin | -30.40% |
| EBITDA Margin | -34.91% |
| EBIT Margin | -34.59% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -23.97% |
| Shareholder Yield | -23.97% |
| Earnings Yield | -16.49% |
| FCF Yield | -13.53% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $38.44 |
| Price Target Difference | 116.44% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 78.91% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Nov 14, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |